Nicola Mumford – Chair of Trustees
Nicola Mumford is a Non-Executive Director and Chairman of the Human Resources Committee at the Royal Bank of Canada Europe Ltd and principal and founder of the jewellery designers Edith & Kiveen. Formerly London Managing Partner and Director at Wragge, Lawrence Graham & Co (Now Gowling WLG) she devised and led the firm’s gender diversity program. Before taking on gender diversity Nicola’s expertise was as a litigation lawyer dealing with international and high profile cases.
The influential Chambers UK directory noted her ‘… completely uncompromising approach to client care.’ Nicola was the first woman chair of the International Bar Association’s Litigation Committee and Wragge & Co’s first female London Managing Partner.
Nicola’s connection with Pancreatic Cancer Action is as a result of her Father being one of the very few and very lucky survivors of the disease having been diagnosed in 2000 and still going strong!
Mr Neville Menezes – Founding Trustee and Consultant HPB surgeon
Mr Neville Menezes is a Consultant Pancreatico-biliary Surgeon and is one of the founder members and Trustees of Pancreatic Cancer Action. He is one of the medical advisors on the panel of doctors for ‘ Pancreatic Cancer Action’. He is appointed as the Consultant HPB Surgeon for the Surrey, West Sussex and Hampshire Cancer network holding Consultant posts at The Royal Surrey County Hospital NHS Foundation Trust in Guildford and Ashford & St. Peter’s Hospital NHS Foundation Trust in Chertsey Surrey.
His specialist surgical training was in the West of Scotland & The South Thames Deanery. He completed his FRCS from The Royal College of Surgeons, Edinburgh and thereafter pursued research & specialist training followed by an Intercollegiate FRCS (Gen. Surg.) in 2002.
His Pancreatico-biliary experience and research related to minimally invasive techniques for intractable pancreatic pain was acquired at the Lister Department of Surgery at the Glasgow Royal Infirmary working with Professor CW Imrie and his Hepatobiliary experience was acquired at King’s College Hospital in London. His Laparoscopic Training was at the Minimal Access Therapeutic Training Unit (MATTU) in Guildford.
He strongly believes that any improvement in pancreatic cancer survival will be related to and as a direct consequence of early diagnosis which is also the primary aim of our charity ‘Pancreatic Cancer Action’.
He is a great advocate of on-site cytology during ERCP & EUS diagnostic techniques and offers it to all his patients diagnosed with pancreatic and biliary cancers.
Stephen Krag – Trustee
Stephen was appointed a trustee of Pancreatic Cancer Action in April 2017.
He is a qualified chartered accountant and worked in the financial services industry for over 30 years for a number of UK and international banks until his retirement in 2019.
Having known a number of close friends who have suffered from cancer he is a strong believer in the value of effective health education in helping early diagnosis and improving life outcomes and is very proud to be associated with a charity focussed on these objectives in relation to pancreatic cancer.
Hugh Goodfellow – Trustee
I lead the Life Sciences team at a leading firm of patent attorneys in London. In that role, I spend much of my time overseeing teams of specialists who assist innovator companies in developing and protecting novel clinical products. These companies range from large and long-established global companies through to smaller European biotech companies. My particular area of current focus includes biologics – in particular, therapeutic antibodies, complex immunological therapies like CAR-T, and stem cells. I received my degree in Biochemistry and DPhil in Molecular Medicine from the University of Oxford. My experience at the bench was spent investigating mechanisms of drug resistance in cancer cells.
Outside of work, I am an adrenaline junkie and spend much of my spare time trying to frighten my family and friends, sometimes also myself.
I became involved as a Trustee at Pancreatic Cancer Action following the death of a close friend from this awful disease. I hope to provide a link between the fund-raising activities of the charity and the process that decides how its funds can be spent most beneficially in line with the charity’s goals.
Ross Carter – Trustee
Mr. Ross Carter is a pancreatic surgeon based in the West of Scotland Pancreatic Unit in Glasgow Royal Infirmary. He is both former Honorary Secretary of the Pancreatic Society of Great Britain and Ireland and former Pancreatic Section of the British Society of Gastroenterology.
Aware of the advances in care and outcomes being driven through charities focused on many cancers, but with a clear absence of a UK pancreatic cancer charity, he became involved in the third sector during the formative years of PCRF, PCUK, and PCA; all based in the South East England.
With key differences between the National Health Service in England & Wales and that in Scotland, Mr. Carter recognised the need for a further pancreatic cancer charity; one focusing on the Scottish perspective. This charity could then implement core objective of raising awareness, advancing research, and improving healthcare standards for patients and carers, in the most effective way for Scotland; whilst working with sister charities on UK-wide projects.
To achieve this vision, along with co-founders Pamela Sinclair, Fred Carenduff, Graham Carson, Elspeth Cowan, Anne Ventisei, and Sarah Beveridge, Mr. Carter launched Pancreatic Cancer Scotland as a Registered Scottish Charity (No SC041740) on 12th November 2010.
Alison Clancy is a qualified teacher with experience in early years, primary and additional support education. She is a mother of 3 girls and was happily married to husband Tommy for 19 years when he received his cancer diagnosis in 2014. Just 4 months later, Tommy died, devastating Alison and her family.
Since then, Alison has been actively involved as a volunteer with Pancreatic Cancer Scotland. Through their time of grief and loss, the family pulled together to raise awareness and much needed funds to improve early diagnosis, supporting the work of the charity.
Alison became a Trustee for the charity in 2016 and has since helped to grow and develop PCS. It has always been at the forefront of Alison’s mind to create a support network for PC patients and their families, something she wishes she had available to her and her family during their journey.